5 completed, 1 recruiting, 1 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Recruiting 1, Withdrawn 1 |
Follow Schizophreniform Disorders: new trials by email Literature Review of Schizophreniform Disorders trials Research Report on Schizophreniform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia | Phase 4 | Completed | BioXcel Therapeutics Inc | 29 | 2023-10-02 | 2026-08-11 |
| Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia | Phase 4 | Withdrawn | Brigham and Women's Hospital | 2023-09-01 | 2026-01-28 | |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | University of Michigan | 143 | 2020-01-16 | 2026-06-17 |
| Bazedoxifene -Treatment for Women With Schizophrenia Bazedoxifene Acetate, Placebo - Schizophrenia, Schizophreniform Disorders | Phase 4 | Recruiting | The Alfred | 160 | 2019-10-07 | 2026-06-03 |
| Research Into Antipsychotic Discontinuation and Reduction Trial Antipsychotic Reduction, Antipsychotic Maintenance - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | University College, London | 253 | 2016-03-24 | 2022-05-23 |
| Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia Pravastatin, Placebo - Schizophrenia, Schizoaffective Disorders | Phase 4 | Completed | Massachusetts General Hospital | 60 | 2010-06-01 | 2014-04-28 |
| Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia Ramelteon, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Massachusetts General Hospital | 25 | 2008-01-01 | 2012-09-13 |
Psychotic Disorders (7) · Schizophrenia (7) · Bipolar Disorder (3) · Psychomotor Agitation (2) · Diabetes Mellitus (1) · Inflammation (1) · Schizophrenia, Paranoid (1)
Mental Disorders (7) · Schizophrenia Spectrum and Other Psychotic Disorders (7) · Bipolar and Related Disorders (3) · Mood Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Aberrant Motor Behavior in Dementia (2) · Behavior (2) · Behavioral Symptoms (2) · Dyskinesias (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Psychomotor Disorders (2) · Signs and Symptoms (2) · Endocrine System Diseases (1)
Dexmedetomidine (1) · Lorazepam (1) · Pravastatin (1) · bazedoxifene (1) · ramelteon (1)
Massachusetts General Hospital (2) · BioXcel Therapeutics Inc (1) · Brigham and Women's Hospital (1) · The Alfred (1) · University College, London (1) · University of Michigan (1)
United States (4) · Australia (1) · United Kingdom (1)
BioXcel MM, MD (1) · David C Henderson, M.D. (1) · David C. Henderson, M.D. (1) · Joanna Moncrieff, MBBS (1) · Stephan Taylor, MD (1)
R01MH118634 (1)